Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Other financing activities (2022 - 2025)

Invivyd's (IVVD) quarterly Other financing activities came in at $128.5 million in Q4 2025, up 95074.81% on a YoY basis from N/an in Q4 2024, and up 138.19% quarter-over-quarter from $53.9 million in Q3 2025.

Analysis

Invivyd (IVVD) Other financing activities (2022 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Other financing activities for 4 consecutive years, with $128.5 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 95074.81% year-over-year to $128.5 million; the trailing twelve-month figure through Dec 2025 stood at $182.5 million (up 43360.48% YoY), and the FY2025 full-year result was $182.5 million, up 43360.48% from the prior year.
  • Other financing activities advanced to $128.5 million in Q4 2025 per IVVD's latest filing, from $53.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $128.5 million in Q4 2025 and bottomed at $21000.0 in Q4 2022.
  • Historically, Other financing activities has averaged $12.3 million across 4 years, with a median of $97000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2025: Other financing activities tumbled 63.92% in 2023, then soared 95074.81% in 2025.
  • Over 4 years, Other financing activities stood at $21000.0 in 2022, then soared by 1071.43% to $246000.0 in 2023, then tumbled by 45.12% to $135000.0 in 2024, then jumped by 95074.81% to $128.5 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods registered $128.5 million, $53.9 million, and $68000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 128.49 Mn
Sep 30, 2025 53.94 Mn
Jun 30, 2025 68,000.00
Mar 31, 2025 37,000.00
Dec 31, 2024 135,000.00
Sep 30, 2024 97,000.00
Jun 30, 2024 188,000.00
Dec 31, 2023 246,000.00
Sep 30, 2023 35,000.00
Jun 30, 2023 215,000.00
Mar 31, 2023 459,000.00
Dec 31, 2022 21,000.00
Sep 30, 2022 97,000.00
Jun 30, 2022 76,000.00
Mar 31, 2022 47,000.00